June 7, 2016 at 12:05 pm
Shares of Juno Therapeutics  went down by 3% early Tuesday morning but then recovered by 3.7%. By noon, the stock again fell by 1.5%. The reason behind this is its product candidate JCAR015, a treatment for leukemia. The biopharmaceutical company released encouraging clinical data regarding the dr...Read More »